Pricing Log in Create free account

Nuvilex Inc. (PMCB) vs Xenetic Biosciences, Inc. (XBIO)

Nuvilex Inc. and Xenetic Biosciences, Inc. are both Biotechnology companies. Nuvilex Inc. and Xenetic Biosciences, Inc. are of similar size ($4.4M and $4.0M). Xenetic Biosciences, Inc. grew revenue faster over the last twelve months: 33.3% against −71.1%. Nuvilex Inc. has the higher net margin (0.00% vs −75.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Xenetic Biosciences, Inc. leads on 9 and Nuvilex Inc. on 5.

Valuation

Metric PMCB XBIO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1.32 9.40
P/B 0.14 0.71 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 3.77 0.40 0.66
EV/Sales n/m (0.32) 9.02
Earnings yield (650.59%) (64.48%) (32.88%)
Free cash flow yield (266.52%) (53.86%) (23.13%)

Profitability

Metric PMCB XBIO Biotechnology median
Gross margin 95.64% 100.00% 68.51%
Operating margin 0.00% (81.01%) 0.00%
Net margin 0.00% (75.90%) 0.00%
Free cash flow margin 0.00% (70.93%) 0.00%
Return on equity (58.04%) (47.05%) (51.96%)
Return on assets (50.43%) (40.17%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PMCB XBIO Biotechnology median
Revenue growth (TTM) (71.06%) 33.30% 6.76%
EPS growth (last fiscal year) (186.83%) 38.52% 29.88%
Revenue growth, 5-year CAGR — 46.78% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PMCB XBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 40.29 7.43 4.97
Net debt to EBITDA 5.41 2.78 1.01

Dividend

Metric PMCB XBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PMCB XBIO Biotechnology median
Market cap 4.03m 4.37m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack